Watchout for MLL, MTNL in coming days. Limit for Max Retail subscription to IPOs increased to 2 lakhs.

 
Stock View: Ajanta Pharma

The stock has been consolidating between 240 and 260 for weeks now, and is poised for a breakout if it sustains above 260. Buy Ajanta Pharma only if it sustains above 260-261 with stoploss of 255 on closing basis and targets 275/280 in short term.

Have a nice trading day

Regards

Ankit